The glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and the dual agonist for GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors tirzepatide demonstrate remarkable efficacy for diabetes remission and metabolic restoration [90, 91]. Here, GCG is linked to diabetes mellitus.